Overview

Evaluation of the Condition of Rheumatoid Arthritis After Treatment

Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
0
Participant gender:
All
Summary
To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Shinshu University
Collaborator:
Showa Inan General Hospital
Treatments:
Tofacitinib
Criteria
Inclusion Criteria:

- Rheumatoid arthritis

Exclusion Criteria:

- Other connective tissue disease